Vimag Labs has commenced pharmaceutical manufacturing operations at its Jhajjar facility, signaling a significant expansion into India's domestic production landscape. The company has unveiled an ambitious phased investment strategy of approximately Rs 50 crore to strengthen its manufacturing capabilities across the country. This strategic move demonstrates Vimag Labs' commitment to scaling operations and meeting growing domestic demand while establishing itself as a competitive player in India's pharmaceutical manufacturing sector.

Summary auto-generated by AI from the original publisher's content. Editorial standards.